Literature DB >> 8789426

Costimulation in tolerance and autoimmunity.

S Guerder1, R A Flavell.   

Abstract

The two signal model of T cell activation predicts that a second costimulatory signal provided by antigen presenting cells (APC) is required in conjunction with the antigenic signal to trigger T cell activation. Considerable evidence indicates that indeed, T cell activation requires such a costimulatory signal which results, at least in part, from the interaction of CD28 with its ligands B7 expressed on all antigen-presenting cells (APC). The second prediction of the two signal model is that T cell receptor engagement in the absence of such a costimulatory signal would lead to specific inactivation of antigen reactive cells. Thus, tissue cells that do not express costimulatory signals would not trigger T cell activation but rather lead to specific inactivation of auto-reactive T cells. By such a model, tolerance to peripheral antigens would be permanently re-established. We review here the evidence suggesting that the CD28-B7 costimulatory pathway might play an important role in T cell tolerance and in the development of autoimmune responses.

Entities:  

Mesh:

Year:  1995        PMID: 8789426     DOI: 10.3109/08830189509061743

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  3 in total

1.  Skin-specifically transgenic expression of biologically active human cytoxic T-lymphocyte associated antigen4-immunoglobulin (hCTLA4Ig) in mice using lentiviral vector.

Authors:  Wen Jiang; Xiao-Yang Zhou; Lu-lu Wang; Qin Liu; Cang'e Liu; Yong Wang; Hong Wei
Journal:  Transgenic Res       Date:  2011-10-08       Impact factor: 2.788

2.  CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1.

Authors:  K D Carey; T J Dillon; J M Schmitt; A M Baird; A D Holdorf; D B Straus; A S Shaw; P J Stork
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Immunological mechanisms in specific immunotherapy.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Springer Semin Immunopathol       Date:  2003-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.